glp 1 weight loss fda approved Approves First Generic GLP-1 Liraglutide for How Employers Can Optimize Benefits
Description
Retatrutide is a GLP-1 drug, in the same family as Ozempic (semaglutide) and Mounjaro (tirzepatide)

Most adverse effects are associated with improper dosing and excessive intake

Hair loss has also been reported, likely related to rapid weight loss rather than the medication itself

[DOI] [PMC free article] [PubMed] [Google Scholar] 28.Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes
PlexusDx compounded semaglutide therapy is designed to fit your lifestarting at just $149 per monthso understanding when to take your dose helps maximize your personal results

The weight loss effect of GLP-1 drug therapy is very beneficial to patients with diabetes
